Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 151

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 151
---
 routine functions. Average review times at the FDA or comparable foreign regulatory authorities may be subject to the political
process, which is inherently fluid and unpredictable. Disruptions at the FDA or comparable foreign authorities bodies may also slow the
time necessary for new drugs, biological products and medical devices or modifications to these products to be reviewed and/or approved
or certified by necessary government agencies, which would adversely affect our business. For example, over the last several years, the
U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees
and stop critical activities.

| 64 |

Changes in tax laws could
adversely affect the taxes we pay and, as a result, adversely affect our financial condition and results of operations.

Tax laws, regulations,
and administrative practices may be subject to significant change, with or without notice, due to economic, political and other conditions,
and significant judgment is required in applying the relevant provisions of tax law. If such changes were to be adopted or if the tax
authorities were to challenge our application of relevant provisions of applicable tax laws, our financial condition and results of operations
could be adversely affected.

In particular,
the U.S. government may enact significant changes to the taxation of business entities including, among others, an increase in the corporate
income tax rate, the imposition of minimum taxes or surtaxes on certain types of income, significant changes to the taxation of income
derived from international operations, and an addition of further limitations on the deductibility of business interest. For example,
the Inflation Reduction Act of 2022 enacted on August 16, 2022, among other provisions, imposes a 15% minimum tax on the adjusted financial
statement income of certain large corporations, as well as a 1% excise tax on corporate stock repurchases by publicly traded companies.
This act, as well as any other changes to tax laws that are enacted, could adversely affect our tax liability. While certain other draft
legislation has been publicly released and is under development in Congress at this time, the likelihood of these changes being enacted
or implemented is unclear. We are currently unable to predict whether such changes will occur. If such changes are enacted or implemented,
we are currently unable to predict the ultimate impact on our business and therefore there can be no assurance our business will not be
adversely affected.

Healthcare reform initiatives
and other administrative and legislative proposals may adversely affect our business.

There have been,